20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marianne Waldstrøm is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Clinical performance of human papillomavirus (HPV) testing versus cytology for cervical cancer screening: Results of a large danish implementation study

Thomsen, L. T., Kjær, S. K., Munk, C., Frederiksen, K., Ørnskov, D. & Waldstrøm, M., 1. Jan 2020, In : Clinical Epidemiology. 12, p. 203-213

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
  • 34 Downloads (Pure)

    Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma

    Henriksen, J. R., Donskov, F., Waldstrøm, M., Jakobsen, A., Hjortkjaer, M., Petersen, C. B. & Dahl Steffensen, K., 14. Jan 2020, In : Acta oncologica (Stockholm, Sweden). p. 1-8 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  • HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women

    McHome, B. L., Kjaer, S. K., Manongi, R., Swai, P., Waldstroem, M., Iftner, T., Wu, C., Mwaiselage, J. & Rasch, V., 8. Apr 2020, In : Sexually Transmitted Infections.

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Open Access
    File
  • A Danish clinical cervical cytology biobank. Pilot studies of sample processing and quality

    Ørnskov, D., Waldstrøm, M., Thomsen, L. T., Munk, C. & Kjaer, S. K., 2019.

    Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

    Activities

    • 7 Conference presentations
    • 5 Talks and presentations in private or public companies

    Participation in HPV- and cytology-based cervical cancer screening: results from a Danish implementation study

    Louise T Thomsen (Speaker), Christian Munk (Other), Dorthe Ørnskov (Speaker), Susanne Krüger Kjaer (Speaker), Marianne Waldstrøm (Speaker)
    5. Dec 2019

    Activity: Talks and presentationsConference presentations

    HPV test som den primære screeningsmetode for livmoderhalskræft til kvinder i alderen 30-59 år

    Marianne Waldstrøm (Speaker), Louise T Thomsen (Other), Dorthe Ørnskov (Speaker), Christian Munk (Other), Susanne Krüger Kjaer (Other)
    Mar 2019

    Activity: Talks and presentationsConference presentations

    Nanostring nCounter IO 360 genplatform til analyse af cancerprøver

    Martin Sokol (Speaker), Henrik Hager (Speaker), Ann Christina Eriksen (Other), Jon Røikjær Henriksen (Other), Marianne Waldstrøm (Speaker)
    Mar 2019

    Activity: Talks and presentationsConference presentations

    A Danish Clinical Cervical Cytology Biobank. Pilot studies of sample processing

    Dorthe Ørnskov (Speaker), Marianne Waldstrøm (Speaker), Louise T Thomsen (Other), Christian Munk (Other), Susanne Krüger Kjaer (Other)
    Dec 2018

    Activity: Talks and presentationsConference presentations

    For high-risk HPV testing the sensitivity and specificity of a urine sample is similar to self-collected vaginal sample and physician-taken LBC sample

    Dorthe Ørnskov (Speaker), Kirsten Marie Jochumsen (Other), Ivan Moulun Grunnet (Other), Pernille Husted Steiner (Other), Dorthe Ejersbo (Other), Annemette Windfang Lykkebo (Other), Marianne Waldstrøm (Speaker)
    Dec 2018

    Activity: Talks and presentationsConference presentations